1.2. Study aims
CIN
CIN
Our study aim is to test the hypothesis that same-day administration of pegteograstim is non-inferior to next-day administration in controlling CIN Gr4 duration during first cycle in patients treated with chemotherapy regimens that contain intensively myelosuppressive agents on day 1.